Search clinical trials for: Blincyto
Total 70 results
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingALL, AdultNetherlands, Belgium
-
Prof. Christina PetersAmgenTerminatedMinimal Residual Disease | ALL, ChildhoodNorway, Spain, Denmark, Austria, Belgium, Czechia, France, Italy, Poland, Slovakia
-
Goethe UniversityCompletedALL, Recurrent, AdultGermany
-
Goethe UniversityRecruiting
-
Massachusetts General HospitalAmgenCompletedNon-Hodgkin LymphomaUnited States
-
University of Maryland, BaltimoreActive, not recruitingMixed Phenotype Acute Leukemia (MPAL) | Measurable Residual Disease (MRD)United States
-
AmgenNot yet recruitingB Precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
-
Institute of Hematology and Blood Transfusion,...CZECRIN - Czech Clinical Research Infrastructure NetworkCompletedNewly Diagnosed | Lymphoblastic Leukemia, Acute, Adult | Ph Negative ALLCzechia
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Goethe UniversityUniversity Hospital Schleswig-HolsteinRecruiting
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaUnited States, Germany, Austria, Canada, France, Italy, Netherlands
-
AmgenRecruitingB Cell Precursor Acute Lymphoblastic LeukemiaJapan, Australia, Spain, United States, Italy, Germany, France, Turkey, Canada, Netherlands, Austria
-
AmgenAmgen Astellas Biopharma K.K.CompletedRelapsed Refractory B Precursor Acute Lymphoblastic LeukemiaJapan
-
Amgen Research (Munich) GmbHCompleted
-
Amgen Research (Munich) GmbHCompletedDiffuse Large B-cell LymphomaGermany
-
M.D. Anderson Cancer CenterAmgenCompletedAcute Lymphoblastic LeukemiaUnited States
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaUnited States, United Kingdom, Germany, Spain, France, Italy
-
Ascentage Pharma Group Inc.RecruitingMyeloid Leukemia | Chronic Myeloid Leukemia | Philadelphia Positive Acute Lymphoblastic Leukemia | Leukemia, Myeloid, Chronic | B Cell Precursor Type Acute LeukemiaUnited States
-
AmgenCompletedRelapsed/Refractory Philadelphia Positive B-precursor ALLFrance, United States, Germany, Italy, United Kingdom
-
Amgen Research (Munich) GmbHCompletedB-cell Acute Lymphoblastic LeukemiaAustria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Children's Hospital Medical Center, CincinnatiWithdrawnLymphoma, B-Cell | Leukemia, B-cellUnited States
-
Imugene LimitedRecruiting
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
AmgenRecruitingNewly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)Japan, Australia, Denmark, Netherlands, Taiwan, Switzerland, Canada, France, United States, Austria, Italy, Spain, Sweden, Belgium, Hungary, Finland, Greece, Turkey, Romania, Portugal, Germany, Bulgaria, Mexico, United Kingdom
-
Cedars-Sinai Medical CenterAmgenActive, not recruitingB-ALL | B-Cell Acute Lymphoblastic Leukaemia | ALL, AdultUnited States
-
Medical College of WisconsinUniversity of Wisconsin, Madison; AmgenRecruitingB-cell Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | B-Cell ALL, ChildhoodUnited States
-
AmgenRecruitingB-precursor Acute Lymphoblastic LeukemiaUnited States
-
Oslo University HospitalMøre og Romsdal Hospital TrustTerminatedChlamydia Trachomatis Infection | Chlamydial UrethritisNorway
-
AmgenCompleted
-
Ho Joon ImNot yet recruitingAcute Lymphoid LeukemiaKorea, Republic of
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaGermany
-
Amgen Research (Munich) GmbHCompletedNon-Hodgkin's Lymphoma, RelapsedGermany
-
Cardiff UniversityNot yet recruitingAcute Lymphoblastic Leukemia, Adult
-
AmgenTerminatedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Italy, Belgium, Canada, Mexico, Germany, Korea, Republic of, United Kingdom, Taiwan, Australia, Spain, Austria, Israel, Czechia, Greece, Russian Federation, Poland, Turkey, Bulgaria, Ireland
-
Novartis PharmaceuticalsWithdrawn
-
University of California, San DiegoMerck Sharp & Dohme LLC; AmgenActive, not recruitingB-Cell Acute Lymphoblastic Leukemia, AdultUnited States
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
Chen SuningRecruitingALL, Adult | Philadelphia-Negative ALLChina
-
AmgenCompletedAcute Lymphoblastic LeukemiaGermany, United States, France, Australia, Spain, Italy, Netherlands, Austria, United Kingdom
-
AmgenCompletedHigh-risk Diffuse Large B-Cell LymphomaUnited States, Canada, Germany, Spain, France, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AmgenActive, not recruitingAcute Lymphoblastic Leukemia | B-cell Non Hodgkin Lymphoma | Pre B-Cell Acute Lymphoblastic LeukaemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | Adult Acute Lymphoblastic Leukemia in Complete RemissionUnited States
-
M.D. Anderson Cancer CenterAmgenTerminatedHematopoietic/Lymphoid Cancer | Richter's TransformationUnited States
-
Brian JonasNational Cancer Institute (NCI); Pharmacyclics LLC.RecruitingPhiladelphia Chromosome Positive | Adult B Acute Lymphoblastic LeukemiaUnited States
-
St. Jude Children's Research HospitalActive, not recruitingHodgkin Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Chronic Myeloid Leukemia (CML) | NK-Cell Leukemia | Non Hodgkin Lymphoma (NHL) | Juvenile Myelomonocytic Leukemia (JMML)United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingPhiladelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD19 PositiveUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
Washington University School of MedicineAmgenCompletedDiffuse Large B Cell LymphomaUnited States